TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ULTROMICS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ULTROMICS

ST13

US500000079246306

Classe

9, 42, 44

Pedido

79246306

Registro

6224292

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

58

Atualização mais recente

13/07/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 42, 44

Data de depósito

02/10/2018

Data de registro

22/12/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

22/12/2020

Última transação

13/07/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

GB

Examinador

AGREDA, SAMANTHA LEIGH

Unidade examinadora

N50

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Ultromics Limited

Representantes

N. Alexander Nolte Nolte Lackenbach Siegel

Classificação técnica

Classes Nice

Classe 9Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Recorded software for use in medical treatment, namely, for analyzing medical data to provide suggested clinical interpretations for medical treatment purposes; recorded computer software for use in medical diagnosis, namely, for analyzing medical data to provide suggested clinical interpretations for medical diagnosis purposes; recorded software with artificial intelligence for use in diagnosis of medical conditions, namely, for analyzing medical data to provide suggested clinical interpretations for medical diagnosis purposes; recorded software with artificial intelligence for use in treatment of medical conditions, namely, for analyzing medical data to provide suggested clinical interpretations for medical treatment purposes; downloadable databases in the field of cardiology; data banks being downloadable databases in the field of cardiology; data banks being downloadable databases in the field of cardiology for use with medical diagnostic equipment; downloadable software for use in medical diagnosis, namely, for analyzing medical data to provide suggested clinical interpretations for medical diagnosis purposes; downloadable software for use in medical diagnosis, namely, for analyzing medical data to provide suggested clinical interpretations for medical treatment purposes; downloadable application software for handheld computers, namely, software for use in medical diagnosis, namely, for analyzing medical data to provide suggested clinical interpretations for medical diagnosis purposes; downloadable application software for handheld computers, namely, software for use in medical diagnosis, namely, for analyzing medical data to provide suggested clinical interpretations for medical treatment purposes; downloadable computer software for use in medical diagnosis, namely, for analyzing medical data to provide suggested clinical interpretations for medical diagnosis purposes; downloadable computer software for use in medical diagnosis, namely, for analyzing medical data to provide suggested clinical interpretations for medical treatment purposes; downloadable software applications for use in medical diagnosis, namely, for analysis medical data to provide suggested clinical interpretations for medical diagnosis purposes; downloadable software applications for use in medical diagnosis, namely, for analyzing medical data to provide suggested clinical interpretations for medical treatment purposes; downloadable software relating to data analytics being software for analyzing patient data from medical patient monitoring and diagnostic equipment; downloadable artificial intelligence software for use in medical diagnosis, namely, for analyzing medical data to provide suggested clinical interpretations for medical diagnosis purposes; downloadable artificial intelligence software for use in medical diagnosis, namely, for analyzing medical data to provide suggested clinical interpretations for medical treatment purposes; downloadable software for use in the field of medicine and medical diagnosis, namely, for interpreting the results of echocardiograms; echocardiography software being downloadable software for interpreting the results of echocardiograms

Classe 42

Research and development services in the field of cardiology; medical research and development services in the field of cardiology; scientific research and development services; pharmaceutical research and development services; design services, namely, medical diagnostic apparatus and instrument design services; research, design and development of medical apparatus and instruments; research, design and development of medical diagnostic apparatus and instruments; research, design and development of cardiovascular diagnostic testing apparatus and instruments; product design, research and development services in the field of artificial intelligence; design, research, development, maintenance, updating, testing, customization, implementation, installation and rental of software, computer software, software programs, application software and software applications; technical support being software programming, installation, and advisory and information services in the field of software programming and installation; maintenance and repair services for software, computer software, application software and software applications; software as a service (SAAS) services featuring software for use in the field of medicine and medical diagnosis, namely, for analyzing medical data to provide suggested clinical interpretations for medical diagnosis purposes; cloud computing services, namely, cloud hosting provider services

Classe 44

Medical services; medical diagnostic services; medical imaging services; providing medical information to medical professionals in the form of medical reports in the field of cardiology; medical screening relating to the heart; medical services, namely, medical testing, screening and analysis for diagnostic or treatment purposes; medical services, namely, medical testing, screening and analysis services relating to the diagnosis and treatment of disease; medical services, namely, medical testing, screening and analysis services relating to the diagnosis and treatment of cardiovascular disease

Publicações

Histórico de despachos e eventos da marca no USPTO.

58 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

13/07/2026

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

13/07/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

13/07/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

13/07/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

13/07/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

13/07/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

22/12/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

27/05/2022

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

02/07/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

16/05/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

26/03/2021

FIMP

FINAL DISPOSITION PROCESSED

25/03/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

22/03/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

22/12/2020

GPNX

NOTIFICATION PROCESSED BY IB

25/10/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/10/2020

PUBO

PUBLISHED FOR OPPOSITION

06/10/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

30/09/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

30/09/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

16/09/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/09/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

31/08/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

30/08/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

30/08/2020

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

15/05/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/05/2020

GNRT

NON-FINAL ACTION E-MAILED

11/05/2020

CNRT

NON-FINAL ACTION WRITTEN

11/05/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

29/04/2020

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

29/04/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

17/04/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

16/04/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

16/04/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

21/11/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

16/10/2019

GNRT

NON-FINAL ACTION E-MAILED

16/10/2019

CNRT

NON-FINAL ACTION WRITTEN

16/10/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/09/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/09/2019

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

03/09/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/09/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/09/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

26/07/2019

CNFR

FINAL REFUSAL MAILED

03/06/2019

CNFR

FINAL REFUSAL WRITTEN

31/05/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/05/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/05/2019

ALIE

ASSIGNED TO LIE

06/05/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

29/04/2019

RFNT

REFUSAL PROCESSED BY IB

22/02/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/02/2019

RFRR

REFUSAL PROCESSED BY MPU

05/02/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

23/01/2019

CNRT

NON-FINAL ACTION WRITTEN

22/01/2019

DOCK

ASSIGNED TO EXAMINER

12/01/2019

MAFR

APPLICATION FILING RECEIPT MAILED

04/12/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

30/11/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

29/11/2018

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ULTROMICS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.